Global Antibiotics Market 2022-2028

March 2022 | 78 pages | ID: GBFF55436181EN
Gen Consulting Company

Abstracts

Antibiotics, also known as antibacterials, are used to treat or prevent some types of bacterial infection. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply. According to market research study published by Gen Consulting Company, the global antibiotics market is expected to reach approximately USD 57,435 million, representing a CAGR of 4.3% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global antibiotics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the antibiotics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug class, action mechanism, spectrum, route of administration, and region. The global market for antibiotics can be segmented by drug class: aminoglycosides, carbapenems, cephalosporins, fluoroquinolones, macrolides, penicillin, tetracyclines, others. Antibiotics market is further segmented by action mechanism: cell wall inhibitors, DNA inhibitors, protein inhibitors, others. The cell wall inhibitors segment is estimated to account for the largest share of the global antibiotics market. Based on spectrum, the antibiotics market is segmented into: broad-spectrum antibiotics, narrow-spectrum antibiotics. On the basis of route of administration, the antibiotics market also can be divided into: oral, topical, others. In 2021, the oral segment made up the largest share of revenue generated by the antibiotics market. Antibiotics market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By drug class:

• aminoglycosides
• carbapenems
• cephalosporins
• fluoroquinolones
• macrolides
• penicillin
• tetracyclines
• others

By action mechanism:

• cell wall inhibitors
• DNA inhibitors
• protein inhibitors
• others

By spectrum:

• broad-spectrum antibiotics
• narrow-spectrum antibiotics

By route of administration:

• oral
• topical
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global antibiotics market. Some of the leading players profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global antibiotics market.
• To classify and forecast the global antibiotics market based on drug class, action mechanism, spectrum, route of administration, region.
• To identify drivers and challenges for the global antibiotics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antibiotics market.
• To identify and analyze the profile of leading players operating in the global antibiotics market.

Why Choose This Report

• Gain a reliable outlook of the global antibiotics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY DRUG CLASS

Aminoglycosides
Carbapenems
Cephalosporins
Fluoroquinolones
Macrolides
Penicillin
Tetracyclines
Others

PART 6. MARKET BREAKDOWN BY ACTION MECHANISM

Cell wall inhibitors
DNA inhibitors
Protein inhibitors
Others

PART 7. MARKET BREAKDOWN BY SPECTRUM

Broad-spectrum antibiotics
Narrow-spectrum antibiotics

PART 8. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Oral
Topical
Others

PART 9. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 10. KEY COMPANIES

Abbott Laboratories
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER